Program:Identification of clinically applicable biological markers and drug targets in schizophrenia

National Key Research and Development Project (Precise Medicine)

PI：Raymond CK Chan

The project aims to address the key scientific issue of the identification of clinically applicable biomarkers and drug targets in schizophrenia. We have collected data of clinical information, genetic types, behavioural tasks and brain imaging. By integrating these data, it is hopefully for us to identify the biomarkers and drug targets in patients with schizophrenia spectrum disorders. These findings will have potential implications for early identification, diagnosis, medical treatment and prognosis.